Glycanostics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Upcoming)

  • Latest Deal Amount
  • $5.8M

  • Investors
  • 6

Glycanostics General Information

Description

Developer of cancer diagnostics equipment designed to provide accurate, affordable and non-invasive tests for cancer. The company's diagnostics technology includes prostate cancer kit products for use analysis of glycan changes on specific proteins, like a prostate-specific antigen (PSA), enabling doctors to make a proper decision about the need to perform a biopsy or to check the patient after the biopsy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Kudlákova 7
  • Bratislava, 841 01
  • Slovakia
+421 0911
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • Kudlákova 7
  • Bratislava, 841 01
  • Slovakia
+421 0911

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Glycanostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC $5.8M Upcoming Generating Revenue
6. Accelerator/Incubator 01-Jan-2023 Completed Generating Revenue
5. Equity Crowdfunding 01-Jun-2022 Completed Generating Revenue
4. Grant 01-Oct-2021 Completed Generating Revenue
3. Seed Round 07-Oct-2020 Completed Generating Revenue
2. Grant 10-Oct-2019 $110K Completed Generating Revenue
1. Grant 10-Dec-2018 $56.8K Completed Generating Revenue
To view Glycanostics’s complete valuation and funding history, request access »

Glycanostics Patents

Glycanostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026195647-A1 Calibration curve generated using known amounts of wfl-detectable fpsa obtained from lncap cells Pending 17-Mar-2025
AU-2023251663-A1 Means and methods for high-throughput glycoprofiling of proteins Pending 12-Apr-2022
EP-4508429-A1 Means and methods for high-throughput glycoprofiling of proteins Pending 12-Apr-2022
US-20250258166-A1 Means and methods for high-throughput glycoprofiling of proteins Pending 12-Apr-2022
WO-2023198337-A1 Means and methods for high-throughput glycoprofiling of proteins Inactive 12-Apr-2022 G01N33/54313
To view Glycanostics’s complete patent history, request access »

Glycanostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Glycanostics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Medical Forge Accelerator/Incubator
European Innovation Council Accelerator/Incubator Minority
CB Investment Management Growth/Expansion Minority
Slovak Investment Holding Growth/Expansion Minority
Nadaciaeset Government
You’re viewing 5 of 6 investors. Get the full list »

Glycanostics FAQs

  • When was Glycanostics founded?

    Glycanostics was founded in 2017.

  • Where is Glycanostics headquartered?

    Glycanostics is headquartered in Bratislava, Slovakia.

  • What is the size of Glycanostics?

    Glycanostics has 20 total employees.

  • What industry is Glycanostics in?

    Glycanostics’s primary industry is Diagnostic Equipment.

  • Is Glycanostics a private or public company?

    Glycanostics is a Private company.

  • What is Glycanostics’s current revenue?

    The current revenue for Glycanostics is .

  • How much funding has Glycanostics raised over time?

    Glycanostics has raised $2.18M.

  • Who are Glycanostics’s investors?

    Medical Forge, European Innovation Council, CB Investment Management, Slovak Investment Holding, and Nadaciaeset are 5 of 6 investors who have invested in Glycanostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process